CDER Director Sees Behind-The-Counter Switches As Best Bet

By Malcolm Spicer / Email the Author / “The Tan Sheet” Apr. 11, 2011, Vol. 19, No. 15
Word Count: 1537 / Article # 05110411013

Executive Summary

FDA drug center chief Janet Woodcock says behind-the-counter switches would be the most effective method to make Rx drugs available without prescriptions, particularly to help treat chronic conditions.

Purchase this Article

$85.00 Buy Now

For $85.00, purchase this 1537-word article and receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: CDER Director Sees Behind-The-Counter Switches As Best Bet

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to “The Tan Sheet” will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel

CDER Director Sees Behind-The-Counter Switches As Best Bet

Executive Summary

Purchase this Article

Already a Subscriber?

Questions?

Related Articles: 18

Elsevier Business Intelligence Publications

Offers & Events

Topics Covered in this Article

Email Article